NCT04202419View on ClinicalTrials.gov

Nonablative Fractional Diode Laser for Treatment of Pigmented Lesions

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 9, 2020

Primary Completion Date

April 26, 2021

Study Completion Date

April 26, 2021

Conditions
Pigmented Skin Lesion
Interventions
DEVICE

FRAX 1940 nm laser

A fractional 1940 nm solid-state diode laser will deliver linear arrays of microbeams to create nonablative microscopic treatment zones (MTZs) in the skin, in order to treat pigmented skin lesions.

Trial Locations (1)

33173

Miami Dermatology and Laser Institute, Miami

Sponsors
All Listed Sponsors
collaborator

Miami Dermatology and Laser Institute

OTHER

lead

Candela Corporation

INDUSTRY

NCT04202419 - Nonablative Fractional Diode Laser for Treatment of Pigmented Lesions | Biotech Hunter | Biotech Hunter